Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01414/full |
_version_ | 1823925467990720512 |
---|---|
author | Chiara Nicolazzo Francesca Belardinilli Salvatore Caponnetto Angela Gradilone Enrico Cortesi Giuseppe Giannini Giuseppe Giannini Paola Gazzaniga |
author_facet | Chiara Nicolazzo Francesca Belardinilli Salvatore Caponnetto Angela Gradilone Enrico Cortesi Giuseppe Giannini Giuseppe Giannini Paola Gazzaniga |
author_sort | Chiara Nicolazzo |
collection | DOAJ |
first_indexed | 2024-12-16T20:09:08Z |
format | Article |
id | doaj.art-fa6a122ffdbb4e5288ec66ede710eb1c |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-16T20:09:08Z |
publishDate | 2019-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-fa6a122ffdbb4e5288ec66ede710eb1c2022-12-21T22:18:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-12-01910.3389/fonc.2019.01414510181Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal CancerChiara Nicolazzo0Francesca Belardinilli1Salvatore Caponnetto2Angela Gradilone3Enrico Cortesi4Giuseppe Giannini5Giuseppe Giannini6Paola Gazzaniga7Liquid Biopsy Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, ItalyLiquid Biopsy Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyInstitute Pasteur-Cenci Bolognetti Foundation, Rome, ItalyLiquid Biopsy Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italyhttps://www.frontiersin.org/article/10.3389/fonc.2019.01414/fullctDNARASEGFR inhibitiorsliquid biopsycolorectal cancer |
spellingShingle | Chiara Nicolazzo Francesca Belardinilli Salvatore Caponnetto Angela Gradilone Enrico Cortesi Giuseppe Giannini Giuseppe Giannini Paola Gazzaniga Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer Frontiers in Oncology ctDNA RAS EGFR inhibitiors liquid biopsy colorectal cancer |
title | Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer |
title_full | Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer |
title_fullStr | Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer |
title_full_unstemmed | Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer |
title_short | Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer |
title_sort | why the therapeutic impact of ras mutation clearance in plasma ctdna deserves to be further explored in metastatic colorectal cancer |
topic | ctDNA RAS EGFR inhibitiors liquid biopsy colorectal cancer |
url | https://www.frontiersin.org/article/10.3389/fonc.2019.01414/full |
work_keys_str_mv | AT chiaranicolazzo whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT francescabelardinilli whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT salvatorecaponnetto whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT angelagradilone whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT enricocortesi whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT giuseppegiannini whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT giuseppegiannini whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer AT paolagazzaniga whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer |